Royal Bank Of Canada Eledon Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.54 - $2.13 $104 - $144	-68 Reduced 62.96%	40 $0
Q4 2023 Feb 14, 2024	SELL	$1.12 - $1.86 $177,070 - $294,064	-158,099 Reduced 99.93%	108 $0
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.66 $131,257 - $191,129	-115,138 Reduced 42.12%	158,207 $216,000
Q2 2023 Aug 14, 2023	BUY	$1.34 - $2.85 $366,282 - $779,033	273,345 New	273,345 $374,000
Q3 2022 Nov 14, 2022	BUY	$2.45 - $3.88 $93 - $147	38 New	38 $0

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.